PART OF THE HOSPITAL CONCIERGE ADVOCATE
Full hospital product, education and cost model →HEART RESERVE · hospital discussion · 22 October 2026
A proposed postpartum hypertension pilot connecting blood-pressure monitoring, plain-language education and an accountable clinical team.
Prepared by Lisa Zahakos, RPA-C. Courtney Williams is an advisor and collaborator; Emagine platform scope, responsibilities, licensing and costs require agreement. A hospital clinical service would own care decisions and response coverage.
First decision: test whether the Heart Story extension adds useful understanding and follow-through to the hospital’s existing care process. Review the narrower ask, objections, workload and funding questions →
2024 · observational cohort
Among 12,038 patients with hypertensive disorders of pregnancy, home BP monitoring with nursing management was associated with fewer six-week readmissions: aRR 0.78 (95% CI 0.65–0.93); adjusted absolute difference −1.5 percentage points.
That point estimate equals about 15 fewer readmissions per 1,000 under comparable conditions. It is a planning illustration, not a forecast, causal finding or mortality claim.
2025 · randomized-trial review
Four trials involving 714 participants did not establish a statistically significant reduction in hypertension-related readmissions. Emergency-department visits were more frequent with remote monitoring.
These studies and outcomes differ. The findings justify measuring both benefits and unintended effects, with no promise of fewer admissions or deaths.
Proposed care model
The app supports the clinical service. Before launch, the hospital must approve the protocol, receiving team, coverage hours, response expectations and backup arrangements.
The clinical team confirms eligibility after a hypertensive pregnancy, the monitoring window and an individual care plan. Provide an appropriate validated cuff, fit and technique training, language support and a teach-back check. Confirm contact details and barriers to access.
Proposed Bluetooth BP/pulse import should retain measurement time, device and connection status. Offer manual entry and a telephone alternative, clearly labeled by source. Ask about symptoms, medicine use and access barriers. Missing data must remain “missing,” never “normal.” The cited findings do not establish a benefit specific to Bluetooth.
Show the hospital-approved instructions alongside short “what to do / why it matters” education. Emergency symptoms must direct the patient to urgent help immediately, without waiting for a message reply. Symptom guidance must not depend on a reassuring BP number.
The receiving nursing service reviews the queue under the signed protocol; a named prescribing service makes treatment decisions. Specify backup coverage, after-hours instructions, failed uploads, overdue reviews, missed readings and unreachable-patient procedures. An unanswered message is not completed care.
Record patient contact, clinician assessment, treatment or referral, the next check and who owns it. Confirm that the patient understands the plan and can obtain medicines or attend care. Preserve a timestamped audit trail.
At the planned handoff, share the pregnancy complication, BP trend, medicines and unresolved actions with the next clinician. Continue visit preparation and Life’s Essential 8 education, adapted to postpartum recovery and the clinician’s plan. The end of the 90-day service episode must not become an automatic end to needed care.
Production states should describe evidence of delivery and care, with timestamps and an overdue pathway. They must never be inferred from pressing “save.”
| Patient-facing status | What it must mean |
|---|---|
| Saved on this device | Stored locally; not sent or reviewed. This is the prototype’s current limit. |
| Received by your care team | The clinical system acknowledged delivery; clinical review is still pending. |
| Reviewed by your care team | A named clinician recorded a review and its time. |
| Your care plan is confirmed | Advice and next steps were communicated and acknowledged; action remains open until follow-up is completed or formally handed over. |
Proposed Phase One targets: 90% complete a timely clinically reviewed early BP evaluation; 80% complete a qualifying postpartum visit within 7–84 days after delivery; 80% have an accepted continuing-care handoff by the end of their 90-day episode. Report all 50 service recipients, including missing outcomes. See the common goals and definitions →
| Measure | How to evaluate it |
|---|---|
| 30- and 90-day ED visits and readmissions | Prespecify all-cause and hypertension-related outcomes separately after birth-hospital discharge, aligned with the agreed comparison window. Report denominators, enrollment timing, outside-hospital events and missing data. |
| Emergency visits and severe complications | Report separately. Use prespecified clinical review to assess timeliness and possible avoidability. Appropriate emergency care is not program failure. |
| Time to care | Reading or symptom time → receipt → review → patient contact → treatment decision → confirmed next step. Count overdue, failed and after-hours events. |
| Reach, understanding and burden | Measure uptake, retention, reading completion, comprehension, access barriers and missingness. Examine differences by relevant patient groups where sample size permits; include staff time and alert burden. |
| Cost per patient | Use hospital costs for staff, devices, connectivity, licensing, onboarding, support and implementation, plus actual acute-care utilization. Distinguish costs from charges and reimbursement. |
Economic scenario: enrolled patients × assumed absolute readmission reduction × local cost per readmission, minus program costs and any additional care costs. Show a zero-benefit scenario and scenarios with higher utilization. Do not present the 1.5-point estimate as a promised saving.
Study design: The proposed 50-service-recipient, $100,000 / 12-month concept is a feasibility proposal. Use a statistician to define the comparator, sample size, confounding adjustment and confidence intervals for any effectiveness study. An uncontrolled before-and-after result cannot establish causation, and a small pilot cannot establish a mortality benefit.
Define service ownership, evidence for launch decisions, the budget, per-episode licensing assumptions and evaluation criteria in one printable discussion brief.
Open the hospital pilot workbench →